ZeptoMetrix Launches PROtrol: Quality Control Material for the Lateral Flow Immunoassay Market

BUFFALO, NY / ACCESSWIRE / May 16, 2023 / ZeptoMetrix® is excited to introduce PROtrol TM, a new line of products designed for antigen-based diagnostic methods. These third-party materials mimic a true clinical specimen and can be used to evaluate and monitor the performance of antigen-based assays, including lateral flow immunoassays for infectious diseases. PROtrol […]

Impulse Dynamics Announces 9,000th Patient Milestone Achieved With CCM® Therapy for Heart Failure

Momentum Continues as Depth of Clinical Experience Expands Worldwide MARLTON, N.J., May 15, 2023 (GLOBE NEWSWIRE) — Impulse Dynamics plc, a global medical device company dedicated to improving the lives of people with heart failure (HF), announced today a worldwide milestone achievement with the 9,000th patient receiving the Optimizer® system for the treatment of moderate […]

Impulse Dynamics Announces 9,000th Patient Milestone Achieved With CCM® Therapy for Heart Failure

Momentum Continues as Depth of Clinical Experience Expands Worldwide MARLTON, N.J., May 15, 2023 (GLOBE NEWSWIRE) — Impulse Dynamics plc, a global medical device company dedicated to improving the lives of people with heart failure (HF), announced today a worldwide milestone achievement with the 9,000th patient receiving the Optimizer® system for the treatment of moderate […]

Insilico Medicine Appoints Michael Bayewitch as VP, Business Development and Strategy

Abu Dhabi, May 15, 2023 (GLOBE NEWSWIRE) — Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, has appointed Michael Bayewitch, PhD, as Vice President (VP) of Business Development and Strategy. Based on the U.S. West Coast, Dr. Bayewitch will work closely with Alex Zhavoronkov, PhD, founder and CEO, Feng Ren, PhD, Co-CEO […]

Insilico Medicine Appoints Michael Bayewitch as VP, Business Development and Strategy

Abu Dhabi, May 15, 2023 (GLOBE NEWSWIRE) — Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, has appointed Michael Bayewitch, PhD, as Vice President (VP) of Business Development and Strategy. Based on the U.S. West Coast, Dr. Bayewitch will work closely with Alex Zhavoronkov, PhD, founder and CEO, Feng Ren, PhD, Co-CEO […]